posted
The chart does not look too bad for this stock, but I believe there are better stocks available at this time. My reasons are too numerous to mention. I do own some of it. To make money in this stock I believe you must own alot of shares. When it does move I do not believe it's going to move very far. I would be very happywith two cents. Before you buy check this out very carefully.
IP: Logged |
posted
If you want to make money today this is not the one. Later this week they should anounce that their e-comerce site is up and running. BUT if your the patient type and want to make a lot of money I would highly recomend it. I have 1 Mill+ and would buy another if I had the money.
IP: Logged |
posted
i own some it has done nothing for a month aas soon as they go foward with thier plan but it is always just around the conner. the test and trial group won't be done until the end of may and then we will know more about the product. if it works its going to be a winner
IP: Logged |
HUTCHINSON, Kan., April 22, 2005 /PRNewswire-FirstCall via COMTEX/ -- HEE Corporation announced today the launch of its web-based product sales and information site, http://www.hpb84.net . The exclusive international distributor of HPB-84, a nutraceutical (nutritional supplement) developed in India, HEE Corporation (OTC: HCCF) has spent the past year testing and developing the promising remedy for Type II diabetes. The introduction of the website marks the first time HPB-84 has been available for sale to the public.
According to HEE Corporation president Radley Brooks, "Offering HPB-84 for sale is a big move for our company, culminating months of hard work. Ongoing testing is indicating the efficacy of our product, and we decided it was time to make it publicly available for the specific treatment of Type II diabetes. The marketplace interest has been exceptional, and due to the national and international appeal in HPB-84, we believe the best way to serve both our investors and our customers is to enter the market via the worldwide web. Our business plan thus far has centered on R & D., but it's time to add product sales to the mix, at the same time offering new hope to the estimated 18.2 million Americans who suffer from diabetes."
After several months of research, development, and testing, the new website marks the company's initial revenue channel. HPB-84 is sold on the site, with explanatory pages detailing its use and effectiveness. An FAQ page answers common questions dealing with product ingredients, potential side effects and interactions with other supplements and/or medications. The site also includes a recommended dosing calculator to accurately assess an individual user's needs. The calculator is interactive, assuring optimal results based on a customer's specific information.
Additionally, customers will have the opportunity to post their personal experiences with HPB-84. General information concerning testing, availability and corporate information will also be available. The company is completing plans for its upcoming marketing efforts and advertising campaign, and is in the process of identifying potential international distributors and licensed resellers of HPB-84, as well as other future HEE Corporation products.
Domestic pilot project testing of HPB-84 is nearing completion, with preliminary results indicting that regulated consumption of HPB-84 tablets facilitates the decrease of oral diabetic medications or insulin in some subjects.
Testing will be completed by the end of May 2005, with a final report published in June. Earlier testing indicated the ingestion of the raw herbal ingredient of HPB-84 caused a striking reduction in the need for traditional medications.
For additional information concerning HEE Corporation and HPB-84, visit http://www.HEE-Corp.com . About HEE HEE's headquarters is based in Hutchinson, Kansas.
Forward-Looking Statements:
Statements in this release that are "forward-looking statements" are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially because of factors such as: entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, changes in licensing programs, product price discounts, delays in product development and related product release schedules, sales channel disruption such as the bankruptcy of a major distributor, and reliance on sole source suppliers for key components that could result in delays in product delivery. Also, any of which may cause revenues and income to fall short of anticipated levels; technological shifts; the ability to have access to distribution channels that are controlled by third parties; the risk of unanticipated increased costs; the continued ability to protect the company's intellectual property rights; adverse effects on our business that might result if an unauthorized disclosure of a significant portion of our formula were to occur; the ability to obtain on acceptable terms the right to incorporate in the company's products and services; changes in product and service mix; maturing product life cycles; product sale terms and conditions; the risk that actual or perceived vulnerabilities in our products could adversely affect our revenues; implementation of operating cost structures that align with revenue growth; unavailability of insurance; uninsured losses; adverse results in litigation; unanticipated tax liabilities; the effects of terrorist activity and armed conflict such as disruptions in general economic activity and changes in our operations and security arrangements; the effects of a major earthquake, cyber-attack or other catastrophic event that results in the destruction or disruption of any of our critical business or information technology systems; the level of corporate information technology spending and changes in general economic conditions that affect demand; currency fluctuations; and financial market volatility or other changes affecting the value of our investments that may result in a reduction in carrying value and recognition of losses including impairment charges. Darci Brooks HEE CORPORATION http://www.HEE-Corp.com 620-663-3333
posted
This stock was $1 a share less than a year ago. This one goes up and down on a regular basis ans is easy to make money on. Not huge money, but decent bank anyway. Just watch close it goes down as fast as it goes up.
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
